MARKET

INO

INO

Inovio Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.360
-0.960
-18.05%
After Hours: 4.590 +0.23 +5.28% 19:59 01/28 EST
OPEN
5.67
PREV CLOSE
5.32
HIGH
5.68
LOW
4.280
VOLUME
23.85M
TURNOVER
--
52 WEEK HIGH
5.95
52 WEEK LOW
1.915
MARKET CAP
431.84M
P/E (TTM)
-3.7091
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of INO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

INO News

  • Coronavirus update: Vaccine stocks retreat and airport screening expands to 20 U.S. airports
  • MarketWatch.11h ago
  • The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
  • Benzinga.16h ago
  • Dow ends more than 450 points lower as spread of coronavirus quashes buying sentiment
  • MarketWatch.1d ago
  • Stock market news live: Stocks close lower as coronavirus death toll rises
  • Yahoo Finance.1d ago

More

Industry

Biotechnology & Medical Research
+0.97%
Pharmaceuticals & Medical Research
+0.58%

Hot Stocks

Name
Price
%Change

About INO

Inovio Pharmaceuticals, Inc. (Inovio) is a late-stage biotechnology company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.
More

Webull offers Inovio Pharmaceuticals Inc (INO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.